Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 12.09% is 10% below its 5-year average of 13.50%, near the low end of its 5-year range (11.38%–18.22%).
As of the fiscal period ended Saturday, December 27, 2025. 1.77% above its 12-month average of 11.88%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
12.09%
RETURN ON EQUITY (ROE) AVG TTM
11.88%
RETURN ON EQUITY (ROE) AVG 3Y
12.69%
RETURN ON EQUITY (ROE) AVG 5Y
13.50%
RETURN ON EQUITY (ROE) AVG 10Y
15.02%
RETURN ON EQUITY (ROE) AVG 15Y
15.08%
RETURN ON EQUITY (ROE) AVG 20Y
14.58%
CURRENT VS TTM AVG
+1.77%
CURRENT VS 3Y AVG
-4.71%
CURRENT VS 5Y AVG
-10.42%
CURRENT VS 10Y AVG
-19.51%
CURRENT VS 15Y AVG
-19.80%
CURRENT VS 20Y AVG
-17.10%
SECTOR MEDIAN · HEALTHCARE
11.65%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+3.78%
vs the sector median at left
Henry Schein, Inc.
Market Cap
$10.04B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.15B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$9.70B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$10.41B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$9.32B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$8.79B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$11.31B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.61B
Return on Equity (ROE)
-114.70%
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $10.04B | 12.09% | 11.88% | 12.69% | 13.50% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | -0.17% | 18.91% | 22.60% | 24.60% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Insulet Corp. (PODD)vs › | $9.70B | 26.39% | 25.41% | 19.99% | 14.02% |
| Universal Health Services, Inc. (UHS)vs › | $10.41B | 20.31% | 18.80% | 15.17% | 15.31% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.32B | 3.10% | -8.94% | -15.72% | 1.14% |
| Tempus AI, Inc. (TEM)vs › | $8.79B | -57.18% | -651.33% | -315.37% | -198.08% |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 5.25% | 5.98% | 10.62% | 11.34% |
| DaVita Inc. (DVA)vs › | $11.61B | -114.70% | 329.18% | 200.63% | 164.66% |
| Align Technology, Inc. (ALGN)vs › | $12.21B | 9771.59% | 10.54% | 10.84% | 19.93% |
ROE
12.1%
ROA
3.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-27 | 12.27% |
| 2024-12-28 | 11.49% |
| 2023-12-31 | 11.38% |
| 2022-12-31 | 15.61% |
| 2021-12-31 | 18.22% |
| 2020-12-31 | 12.01% |
| 2019-12-31 | 16.94% |
| 2018-12-31 | 18.10% |
| 2017-12-31 | 14.45% |
| 2016-12-31 | 18.14% |
| 2015-12-31 | 16.61% |
| 2014-12-31 | 16.57% |
| 2013-12-31 | 15.94% |
| 2012-12-31 | 14.85% |
| 2011-12-31 | 15.12% |
| 2010-12-31 | 13.51% |
| 2009-12-31 | 14.28% |
| 2008-12-31 | 13.96% |
| 2007-12-31 | 13.20% |
| 2006-12-31 | 12.42% |
| 2005-12-31 | 11.19% |
| 2004-12-31 | 11.59% |
| 2003-12-31 | 13.69% |
| 2002-12-31 | 13.70% |
| 2001-12-31 | 12.84% |
| 2000-12-31 | 9.80% |
| 1999-12-31 | 9.71% |
| 1998-12-31 | 3.52% |
| 1997-12-31 | -0.24% |
| 1996-12-31 | 4.83% |
